Dr Kylie Quinn
Group Leader
Translational Immunology and Nanotechnology Program
RMIT University
kylie.quinn@rmit.edu.au
Research Activities
Dr
Kylie Quinn is a Vice-Chancellor’s Research Fellow at RMIT University, with
long-standing research interests in cellular immunity, ageing, vaccines and
immunotherapy. After a PhD in New Zealand on vaccine strategies for
Tuberculosis, Dr Quinn took post-doctoral positions in Dr Robert Seder’s lab (2008-13;
Vaccine Research Center, NIH), where she defined mechanisms of adjuvancy for a
number of novel vaccines and provided key pre-clinical data for Ebola vaccine
selection by the World Health Organisation in 2014, and in Prof Nicole La
Gruta’s lab (2013-18; University of Melbourne, Monash University), where she
developed a project on how ageing and age-related inflammation limits the
function of CD8 T cells. Now at RMIT, Dr Quinn is building a program of
research focused on improving cellular immune responses in older individuals during
infection, vaccination and new cell-based therapies. Dr Quinn also has
a longstanding interest in issues around equity and diversity and is the ASI Women’s
Initiative Co-ordinator. She also enjoys engaging with the public to talk about
science through a number of forums, including the Scientists in Schools program,
talks at Nerd Nite and Pint of Science and media interviews with the Herald Sun
and the RRR show, Einstein-A-Go-Go.
Techniques/Expertise
Ageing, Vaccination, Immunological Memory, CD8 T cell, Influenza, Tuberculosis, HIV, Cancer, Flow Cytometry
Disease Models
Ageing, Cancer, Influenza, HIV, Listeria, Vaccinia, Mycobacteria